Clinical Trial Update: A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B) [Phase 1]

View source ↗

Summary

Phase 1 study of FOLFIRI (irinotecan, leucovorin, and 5-fluorouracil) plus ramucirumab (IMC-1121B) in colorectal cancer; the trial has completed and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• Ramucirumab (ramucirumab)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Colorectal Carcinoma | Phase 1 | Status: COMPLETED | Results posted: 2014-10-06